What is Phibro Animal Health's market cap?

Phibro Animal Health (PAHC) has a market capitalization of $1.4B and trades on NASDAQ.

What is Phibro Animal Health's revenue and profitability?

Phibro Animal Health generated $1.5B in trailing twelve-month revenue with net income of $95.2M, representing a net margin of 6.3%. Gross margin stands at 32.5%, with free cash flow of $12.8M. These figures are based on the Q1 2026 filing.

Who are Phibro Animal Health's competitors?

Phibro Animal Health's key competitors include Elanco Animal Health, Merck & Co., Inc., Zoetis Inc., and others. These companies compete in similar markets and product categories.

Who does Phibro Animal Health partner with?

Phibro Animal Health's notable partners include Zoetis Inc..

Where is Phibro Animal Health headquartered?

Phibro Animal Health is headquartered in United States of America and employs approximately 1,920 people. It has been publicly traded since 2014.

Phibro Animal Health

PAHC

Phibro Animal Health Corporation is a global provider of animal health and mineral nutrition solutions, serving the livestock, aquaculture, and companion animal markets.

Market cap

$1.43B+26.3%

Revenue$1.5B+26.0%

Net income$95.2M+200%

Free cash flow$12.8M-74.0%

EPS (diluted)$2.34+200%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q3 2026 report

May 6, 2026

Revenue$383.5MBeat by $16.5M EPS$0.76Beat by $0.04

Read the full report

Next report

Aug 26, 2026 (In 4 weeks)

Revenue estimate$381.2M

EPS estimate$0.72

Financials

Q3 2026

Income statement

See full

Revenue$383.5M+10.3%

Gross profit$125.7M+20.2%

Operating income$44.7M+33.2%

Net income$24.0M+15.1%

EPS (diluted)$0.59+15.7%

Balance sheet

See full

Cash & equivalents$54.9M-9.0%

Total debt$32.3M+27.8%

Total equity$361.8M+36.0%

Total assets$1.4B+9.7%

Cash flow

See full

Operating cash flow$16.2M-62.4%

CapEx$15.3M+97.7%

Free cash flow$890.0K-97.5%

Valuation & ratios

Valuation

See full

Market cap$1.43B+26.3%

Enterprise value$1.41B+20.9%

P/E15×-9.3×

P/S1×0.0×

Profitability

See full

Gross margin32.5%+0.9pp

Operating margin12%+4.0pp

Net margin6.3%+3.7pp

FCF margin0.9%-3.3pp

Returns & leverage

See full

Return on equity30.3%+18.5pp

Debt / equity0.1×0.0×

Current ratio3.2×+0.3×

Segments

By product

See full

Medicated Feed Additives And Others$205.8M+13.3%

Mineral Nutrition$73.4M+9.9%

Nutritional Specialties$46.8M+8.0%

Vaccines$38.6M+15.7%

Performance Products$18.9M-16.6%

By segment

See full

Animal Health$291.2M+12.7%

Mineral Nutrition$73.4M+9.9%

Performance Products$18.9M-16.6%

By geography

See full

Latin America And Canada$75.6M+6.9%

EMEA$44.5M+14.3%

Asia Pacific$30.7M+8.7%

Competitors

By market cap

Merck & Co.$322.95B+53.0%

Archer Daniels Midland$40.1B+52.4%

Zoetis$32.2B-52.0%

Elanco Animal Health Inc.$12.7B+75.3%

Balchem$5.3B+7.8%

Neogen$2.0B+72.8%

Phibro Animal Health$1.4B+21.9%

PetMed Express$42.1M-42.6%

By revenue growth

Phibro Animal Health+26.0%

Elanco Animal Health Inc.+10.5%

Balchem+9.6%

Merck & Co.+2.9%

Zoetis+2.6%

Archer Daniels Midland-3.9%

Neogen-3.9%

By net margin

Zoetis27.79%+0.9pp

Balchem14.95%+0.8pp

Merck & Co.13.59%-13.7pp

Phibro Animal Health6.35%+3.7pp

Archer Daniels Midland1.34%-0.3pp

Elanco Animal Health Inc.-4.95%-13.6pp

Neogen-69.94%-16.4pp

Profile

Phibro Animal Health Corporation is a global provider of animal health and mineral nutrition solutions, serving the livestock, aquaculture, and companion animal markets. The company develops and manufactures a diverse portfolio of products designed to prevent and treat diseases while enhancing nutritional well-being in food-producing animals and pets. Its operations span approximately 90 countries, leveraging a consolidated sales and distribution network to reach large-scale commercial farms and veterinarians.

Competitive position

A leading global player in the medicated feed additive and mineral nutrition markets with a significant presence in large-scale commercial livestock production.

GeographiesNorth America, Latin America, Asia Pacific, Europe, Africa, Middle East

Customer segmentsCommercial livestock farms, Veterinary clinics, Feed manufacturers, Industrial chemical users

Business modelManufacturing, B2B Distribution, Direct-to-Producer Sales

SuppliersRaw chemical suppliers, Mineral ore providers, Biotechnology research partners, Contract manufacturers

CustomersIntegrated livestock producers, Commercial feed mills, Veterinary distributors, Industrial chemical processors

CountryUnited States of America

Listed2014

Employees1.9K

CEODaniel Bendheim

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Websitepahc.com

FilingsSEC EDGAR

Ask your AI about Phibro Animal Health.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phibro Animal Health's market cap?: Phibro Animal Health (PAHC) has a market capitalization of $1.4B and trades on NASDAQ.
What is Phibro Animal Health's revenue and profitability?: Phibro Animal Health generated $1.5B in trailing twelve-month revenue with net income of $95.2M, representing a net margin of 6.3%. Gross margin stands at 32.5%, with free cash flow of $12.8M. These figures are based on the Q1 2026 filing.
Who are Phibro Animal Health's competitors?: Phibro Animal Health's key competitors include Elanco Animal Health, Merck & Co., Inc., Zoetis Inc., and others. These companies compete in similar markets and product categories.
Who does Phibro Animal Health partner with?: Phibro Animal Health's notable partners include Zoetis Inc..
Where is Phibro Animal Health headquartered?: Phibro Animal Health is headquartered in United States of America and employs approximately 1,920 people. It has been publicly traded since 2014.